# OptiBiotix Health plc Richard Colin Neil Davidson CBE now Non-Executive Chairman

- Link: https://www.directorstalkinterviews.com/optibiotix-health-plc-richard-colin-neil-davidson-cbe-now-non-executive-chairman/412743178
- Published: 2018-01-08T07:21:45+00:00
- Author: Giles Arbor

**OptiBiotix Health plc** (LON: OPTI), a life sciences business developing compounds
to tackle obesity, high cholesterol, diabetes announced today that further to the
announcement dated 5 December 2017, Richard Colin Neil Davidson CBE has been appointed
as Non-Executive Chairman to the Company. Simultaneous with Mr Davidson’s appointment,
Adam Reynolds, as previously disclosed, has stepped down as a director of the Company.

OptiBiotix was formed in March 2012 to develop compounds which modify the human 
microbiome – the collective genome of the microbes in the body – to prevent and 
manage human disease.

The aim of the company is to discover and develop microbial strains, compounds and
formulations, which modulate the human microbiome and can be used as food ingredients
and supplements or active compounds for the prevention and management of human metabolic
diseases, examples of which include obesity, cholesterol and lipid distribution 
and diabetes.

OptiBiotix Health Plc has established a pipeline of microbiome modulators that can
impact on lipid and cholesterol management, energy harvest and appetite suppression.
The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic
® platform technologies designed to identify metabolic pathways and compounds that
impact on human physiology and bring potential health benefits.

Share on: